Qdenga Evropska unija - slovenščina - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - cepiva - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) Evropska unija - slovenščina - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - reasortantni virus gripe (živi oslabljen) s sevom: a / vietnam / 1203/2004 (h5n1) - gripa, človek - cepiva - preprečevanje gripe pri uradno prijavljeni pandemični situaciji pri otrocih in mladostnikih od 12. meseca do starosti manj kot 18 let. pandemije gripe cepiva proti h5n1 astrazeneca je treba uporabljati v skladu z uradnimi smernice.

Jcovden (previously COVID-19 Vaccine Janssen) Evropska unija - slovenščina - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - cepiva - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Evropska unija - slovenščina - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - cepiva - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Vaxxitek HVT+IBD Evropska unija - slovenščina - EMA (European Medicines Agency)

vaxxitek hvt+ibd

boehringer ingelheim vetmedica gmbh - rekombinantne turčija herpesvirus, sev vhvt013-69, v živo - immunologicals za aves, domačo kokošjo, immunologicals - embryonated eggs; chicken - za aktivno imunizacijo piščancev:Če želite preprečiti, umrljivost in zmanjšati klinični znaki in poškodb nalezljivih bolezni bursal. za zmanjšanje umrljivosti, klinični znaki in poškodbah marek je bolezen.

Suiseng Diff/A Evropska unija - slovenščina - EMA (European Medicines Agency)

suiseng diff/a

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - prašiči - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

PreHevbri Evropska unija - slovenščina - EMA (European Medicines Agency)

prehevbri

vbi vaccines b.v. - površinski antigen hepatitisa b - hepatitis b - cepiva - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Ixiaro Evropska unija - slovenščina - EMA (European Medicines Agency)

ixiaro

valneva austria gmbh - japonski-encefalitisni virus, inaktiviran (oslabljeni sev sa14-14-2, vzgojen v vero celicah) - encephalitis, japanese; immunization - cepiva - zdravilo ixiaro je indicirano za aktivno imunizacijo proti japonskemu encefalitisu pri odraslih, mladostnikih, otrocih in dojenčkih, starih dva meseca in več. ixiaro je treba upoštevati za uporabo v posameznikov na tveganje izpostavljenost zaradi potovanja ali, ki so v svojem poklicu.

ProQuad Evropska unija - slovenščina - EMA (European Medicines Agency)

proquad

merck sharp & dohme b.v. - virus, živi oslabljeni, ošpice, virus, živi oslabljeni, mumps, virus, živi oslabljeni, rdečkam, virus, živi oslabljen, noric - chickenpox; rubella; measles; mumps; immunization - cepiva - zdravilo proquad je indicirano za sočasno cepljenje proti ošpicam, mumpsu, rdečkam in noricam pri osebah, starih od 12 mesecev. proquad se lahko upravljajo posamezniki iz 9 mesecev starosti v posebnih okoliščinah (e. tako , da so skladni z nacionalnimi cepljenje urnike, izbruh situacijah, ali potovanje v regiji z visoko razširjenost ošpicam.

Abrysvo Evropska unija - slovenščina - EMA (European Medicines Agency)

abrysvo

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infekcije respiratornih sincicijskih virusov - cepiva - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. glej poglavja 4. 2 in 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.